Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Fish oil supplements & heart disease | Texas cardiologist, World Series-winning third basemen dies at 96
Friday, March 26, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Fish oil supplements lower the risk of heart disease—but only for patients with the right genetic makeup

“What we found is that fish oil supplementation is not good for everyone," one researcher explained. "It depends on your genotype.”

READ MORE >
Apixaban may be a more effective treatment option than rivaroxaban for patients presenting with atrial fibrillation (AFib) and valvular heart disease (VHD), according to a new analysis published in Annals of Internal Medicine.
Share on Twitter Share on Facebook Share on Linkedin

Fish oil supplements lower the risk of heart disease—but only for patients with the right genetic makeup

Share on Twitter Share on Facebook Share on Linkedin
Apixaban may be a more effective treatment option than rivaroxaban for patients presenting with atrial fibrillation (AFib) and valvular heart disease (VHD), according to a new analysis published in Annals of Internal Medicine.
“What we found is that fish oil supplementation is not good for everyone," one researcher explained. "It depends on your genotype.”
READ MORE >

Bobby Brown, Texas cardiologist and World Series-winning third basemen for the New York Yankees, dies at 96

Brown played for the Yankees for eight seasons, served in the U.S. Army during the Korean War and spent 30 years working in Texas as a cardiologist.

READ MORE >
Bobby Brown, MD
Share on Twitter Share on Facebook Share on Linkedin

Bobby Brown, Texas cardiologist and World Series-winning third basemen for the New York Yankees, dies at 96

Share on Twitter Share on Facebook Share on Linkedin
Bobby Brown, MD
Brown played for the Yankees for eight seasons, served in the U.S. Army during the Korean War and spent 30 years working in Texas as a cardiologist.
READ MORE >

Featured Articles

NOACs associated with a 16% lower risk of bone fractures than warfarin

These findings are especially important, the authors explained, because the number of elderly patients on OACs continues to rise. 

READ MORE >
Elderly
Share on Twitter Share on Facebook Share on Linkedin

NOACs associated with a 16% lower risk of bone fractures than warfarin

Share on Twitter Share on Facebook Share on Linkedin
Elderly
These findings are especially important, the authors explained, because the number of elderly patients on OACs continues to rise. 
READ MORE >

How patient-reported data compare to NYHA classifications for evaluating heart failure

The study’s authors tracked data from more than 2,800 patients with HFrEF, sharing their findings in JAMA Cardiology.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

How patient-reported data compare to NYHA classifications for evaluating heart failure

Share on Twitter Share on Facebook Share on Linkedin
The study’s authors tracked data from more than 2,800 patients with HFrEF, sharing their findings in JAMA Cardiology.
READ MORE >

FDA grants breakthrough device designation to AI-powered ECG analysis tool

Tempus, a Chicago-based healthcare technology company, collaborated with Geisinger on the solution.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

FDA grants breakthrough device designation to AI-powered ECG analysis tool

Share on Twitter Share on Facebook Share on Linkedin
Tempus, a Chicago-based healthcare technology company, collaborated with Geisinger on the solution.
READ MORE >

New legislation with bipartisan support would improve patient access to cardiac, pulmonary rehab programs

The bill, introduced in the House of Representatives, has already gained support from the American College of Cardiology and American Heart Association. 

READ MORE >
Congress dome capitol Washington
Share on Twitter Share on Facebook Share on Linkedin

New legislation with bipartisan support would improve patient access to cardiac, pulmonary rehab programs

Share on Twitter Share on Facebook Share on Linkedin
Congress dome capitol Washington
The bill, introduced in the House of Representatives, has already gained support from the American College of Cardiology and American Heart Association. 
READ MORE >

In Other News

COVID-19 vaccinations prevent infections among healthcare workers

Becoming infected with COVID-19 is unlikely once a person has been vaccinated, according to a study published in the New England Journal of Medicine.

READ MORE >
coronavirus COVID-19 vaccine vaccination
Share on Twitter Share on Facebook Share on Linkedin

COVID-19 vaccinations prevent infections among healthcare workers

Share on Twitter Share on Facebook Share on Linkedin
coronavirus COVID-19 vaccine vaccination
Becoming infected with COVID-19 is unlikely once a person has been vaccinated, according to a study published in the New England Journal of Medicine.
READ MORE >

Lung lesion AI earns FDA’s OK

The FDA has granted 510(k) clearance to clinical decision support software that uses AI to detect small but potentially cancerous lesions in the lungs.

READ MORE >
lung cancer pulmonary nodule chest
Share on Twitter Share on Facebook Share on Linkedin

Lung lesion AI earns FDA’s OK

Share on Twitter Share on Facebook Share on Linkedin
lung cancer pulmonary nodule chest
The FDA has granted 510(k) clearance to clinical decision support software that uses AI to detect small but potentially cancerous lesions in the lungs.
READ MORE >

COVID relief bill slashed insurance premiums for early retirees

The American Rescue Plan Act of 2021, better known as the COVID-19 stimulus package, includes not only $1,400 in cash for every eligible American but also provisions to cut health insurance premiums. The move is proving a boon to retirees, Market Watch is reporting. 

 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

COVID relief bill slashed insurance premiums for early retirees

Share on Twitter Share on Facebook Share on Linkedin
The American Rescue Plan Act of 2021, better known as the COVID-19 stimulus package, includes not only $1,400 in cash for every eligible American but also provisions to cut health insurance premiums. The move is proving a boon to retirees, Market Watch is reporting.   
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme